EMEND 125 mg, powder for oral suspension sachet
Active ingredients: Aprepitant
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for oral suspensionsachetorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- EMEND 125 mg, poudre pour suspension buvable
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 sachet(s) polytéréphtalate (PET) aluminium PEBDL : polyéthylène à basse densité linéaire avec 2 pipettes graduées avec 1 godet mélangeur
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Feb 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61951090CIP73004220CIP133400930042205Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| APRÉPITANTpoudre | 125 mg · un sachet | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.